(2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-2-(difluoromethyl)-1H-indazol-2-ium-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid

C38H41ClF2N5O4S+ — CID 134817042

IUPAC(2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-2-(difluoromethyl)-1H-indazol-2-ium-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid
SMILESCC(=O)N1CC(N2CCC(c3c4cc(-c5nc6cc(C)c([C@H](OC(C)(C)C)C(=O)O)c(-c7ccc(Cl)cc7)c6s5)ccc4[nH][n+]3C(F)F)CC2)C1
InChIInChI=1S/C38H40ClF2N5O4S/c1-20-16-29-34(31(22-6-9-25(39)10-7-22)30(20)33(36(48)49)50-38(3,4)5)51-35(42-29)24-8-11-28-27(17-24)32(46(43-28)37(40)41)23-12-14-44(15-13-23)26-18-45(19-26)21(2)47/h6-11,16-17,23,26,33,37H,12-15,18-19H2,1-5H3,(H,48,49)/p+1/t33-/m0/s1
InChIKeyVCRXRDAJDJAROL-XIFFEERXSA-O
MW737.29 g/mol
LogP8.11
Rot. Bonds8

About (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-2-(difluoromethyl)-1H-indazol-2-ium-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid

(2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-2-(difluoromethyl)-1H-indazol-2-ium-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid (PubChem CID 134817042) has the molecular formula C38H41ClF2N5O4S+ and a molecular weight of 737.29 g/mol. Its IUPAC name is (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-2-(difluoromethyl)-1H-indazol-2-ium-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid.

Molecular Properties

Compound Name(2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-2-(difluoromethyl)-1H-indazol-2-ium-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid
PubChem CID134817042
Molecular FormulaC38H41ClF2N5O4S+
Molecular Weight737.29 g/mol
Exact Mass736.25
IUPAC Name(2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-2-(difluoromethyl)-1H-indazol-2-ium-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid
SMILESCC(=O)N1CC(N2CCC(c3c4cc(-c5nc6cc(C)c([C@H](OC(C)(C)C)C(=O)O)c(-c7ccc(Cl)cc7)c6s5)ccc4[nH][n+]3C(F)F)CC2)C1
InChIInChI=1S/C38H40ClF2N5O4S/c1-20-16-29-34(31(22-6-9-25(39)10-7-22)30(20)33(36(48)49)50-38(3,4)5)51-35(42-29)24-8-11-28-27(17-24)32(46(43-28)37(40)41)23-12-14-44(15-13-23)26-18-45(19-26)21(2)47/h6-11,16-17,23,26,33,37H,12-15,18-19H2,1-5H3,(H,48,49)/p+1/t33-/m0/s1
InChIKeyVCRXRDAJDJAROL-XIFFEERXSA-O
XLogP8.11
TPSA102.64 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms51
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500737.29
LogP ≤ 58.11
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-2-(difluoromethyl)-1H-indazol-2-ium-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-2-(difluoromethyl)-1H-indazol-2-ium-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid?
The IUPAC name of (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-2-(difluoromethyl)-1H-indazol-2-ium-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid (CID 134817042) is (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-2-(difluoromethyl)-1H-indazol-2-ium-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid.
What is the SMILES notation for (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-2-(difluoromethyl)-1H-indazol-2-ium-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid?
The canonical SMILES for (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-2-(difluoromethyl)-1H-indazol-2-ium-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid is CC(=O)N1CC(N2CCC(c3c4cc(-c5nc6cc(C)c([C@H](OC(C)(C)C)C(=O)O)c(-c7ccc(Cl)cc7)c6s5)ccc4[nH][n+]3C(F)F)CC2)C1.
What is the InChIKey of (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-2-(difluoromethyl)-1H-indazol-2-ium-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid?
The InChIKey is VCRXRDAJDJAROL-XIFFEERXSA-O. The full InChI is InChI=1S/C38H40ClF2N5O4S/c1-20-16-29-34(31(22-6-9-25(39)10-7-22)30(20)33(36(48)49)50-38(3,4)5)51-35(42-29)24-8-11-28-27(17-24)32(46(43-28)37(40)41)23-12-14-44(15-13-23)26-18-45(19-26)21(2)47/h6-11,16-17,23,26,33,37H,12-15,18-19H2,1-5H3,(H,48,49)/p+1/t33-/m0/s1.
What are the key properties of (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-2-(difluoromethyl)-1H-indazol-2-ium-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid?
(2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-2-(difluoromethyl)-1H-indazol-2-ium-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid has a molecular weight of 737.29 g/mol, XLogP of 8.11, 8 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-2-(difluoromethyl)-1H-indazol-2-ium-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid is sourced from PubChem (CID 134817042), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).